奥赛利定注射液治疗晚期癌痛的临床疗效与安全性研究

:-
 
晚期癌痛所带来的疼痛症状是持久且严重的,这十分影响患者的生活质量与身心健康,并阻碍肿瘤治疗方案的顺利实施,进而影响患者治疗效果。阿片类药物是治疗中重度癌痛的主要方式,具有明确的镇痛效果,但是,吗啡、芬太尼等具有代表性的传统阿片类药物也存在一定的应用局限性,其主要通过激活μ-阿片受体下游的G蛋白信号通路以发挥镇痛作用,这会在一定程度上激活β-arrestin通路,进而增加呼吸抑制、严重便秘、过度镇静等副作用的发生情况,因此,该类药物不具有临床广泛应用性[1-2]。在此背景下,奥赛利定作为新型阿片类药物应运而生,其可选择性激活G蛋白通路,且不会显著激动β-arrestin通路效应,能够在实现强效镇痛的同时,还可降低由β-arrestin通路激活所介导的不良反应发生率,这十分适合应用在无法耐受传统阿片镇痛药物副作用的患者群体之中[3-4]。基于此,本研究进一步探究奥赛利定注射液治疗晚期癌痛的临床疗效与安全性,如下。

运动干预对老年肌少性肥胖患者疗效的Meta分析

Effects of exercise intervention in elderly patients with Sarcopenia Obesity: a meta-analysis

:-
 
目的 评价不同运动干预对老年肌少性肥胖患者健康状况的干预效果。 方法 计算机检索PubMed、Web of Science、Embase、Cochrane Library、中国知网、万方数据库、维普数据库中关于运动干预老年肌少性肥胖患者的运动干预的随机对照试验,检索时限为建库至2025年8月。采用RevMan 5.4软件进行统计分析。 结果 共计纳入13篇文献,815名参与者。运动可显著改善患者身体质量指数 (P<0.0001)、体脂率 (P=0.001)、四肢骨骼肌质量(P<0.0001)、握力(P=0.007)、步速 (P=0.0003)、起立-行走计时测试用时(P<0.00001),提高患者IGF-1水平(P =0.0003);但IL-6(P =0.96)、血清总胆固醇(P=0.22)未见明显改变。 结论 运动可以有效降低肌少性肥胖患者的身体质量指数、体脂肪, 提高肌少性肥胖患者的身体机能、四肢骨骼肌质量和IGF-1水平,其中多组分运动和抗阻运动效果更加显著。
Objective To evaluate the effect of different exercise intervention on the health status of elderly patients with sarcopenia and obesity. Methods PubMed, Web of Science, Embase, Cochrane Library, CNKI, Wanfang database and VIP database were searched for randomized controlled trials on exercise intervention in elderly patients with sarcopenia and obesity until August 2025.Two researchers independently screened the literature, extracted the data, and evaluated the bias risk of the included studies, and then used RevMan 5. 3 software for statistical analysis. Results a total of 13 articles involving 815 participants were included.Exercise significantly reduced body mass index (P < 0.0001), body fat percentage (P = 0.001), and increased limb skeletal muscle mass (P < 0.0001).Exercise significantly improved the patient's grip strength (P = 0.007), pace (P = 0.0003), and decreased the time spent on the timed up-and-go test (P < 0. 00001).Exercise significantly increased serum IGF-1 levels (P = 0.0003), but did not significantly change serum IL-6 (P = 0.96) and serum total cholesterol (P = 0.22). Conclusion Exercise can effectively reduce the body mass index and body fat, and improve the body function, limb skeletal muscle mass and IGF-1 level in patients with sarcopenia obesity, and the effects of multi-component exercise and resistance exercise are more significant.

Phaco+房角分离术与Phaco+小梁切除术对APACG合并白内障患者的治疗效果对比分析:一项回顾性研究

Comparative analysis of phacoemulsification combined with goniosynechialysis versus phacoemulsification combined with trabeculectomy in patients with APACG complicated with cataract: a retrospective study

:-
 
目的 比较白内障超声乳化吸除术(Phaco)+房角分离术与Phaco+小梁切除术治疗急性原发性闭角型青光眼(APACG)合并白内障的临床价值。方法 回顾性分析2022年1月至2025年1月我院200例APACG合并白内障患者临床资料,根据手术方式分为小梁切除组(Phaco+小梁切除术)与房角分离组(Phaco+房角分离术),每组100例(200眼)。比较两组眼压、视力[最佳矫正视力(BCVA)]、中央前房深度、视盘血流密度[整体视盘血流密度(wiVD)、视盘内血流密度(diVD)]、生活质量[视功能相关生活质量量表-25(NEI-VFQ-25)]及并发症情况。结论 术后1周、1个月、3个月,房角分离组眼压低于小梁切除组,BCVA、中央前房深度大于小梁切除组,wiVD、diVD高于小梁切除组(P<0.05);术后1个月,房角分离组NEI-VFQ-25评分高于小梁切除组(P<0.05),术后3月两组NEI-VFQ-25评分比较无显著差异(P>0.05);房角分离组并发症总发生率(6.50%)低于小梁切除组(13.00%)(P<0.05)。结论 与Phaco+小梁切除术相比,Phaco+房角分离术治疗APACG合并白内障患者能有效控制眼压,增加前房深度,改善视盘血流循环,恢复患者视力,提高生活质量,减少并发症发生率。
Objective To compare the clinical efficacy of phacoemulsification (Phaco) combined with goniosynechialysis and phacoemulsification combined with trabeculectomy in the treatment of acute primary angle-closure glaucoma (APACG) complicated with cataract. Methods The clinical data of 200 patients with APACG complicated with cataract treated in our hospital from January 2022 to January 2025 were retrospectively analyzed. According to surgical procedures, the patients were divided into trabeculectomy group (Phaco combined with trabeculectomy) and goniosynechialysis group (Phaco combined with goniosynechialysis), with 100 patients (200 eyes) in each group. Intraocular pressure, visual acuity [best corrected visual acuity (BCVA)], central anterior chamber depth, optic disc vessel density [whole-image optic disc vessel density (wiVD), disc-inside vessel density (diVD)], quality of life [25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)] and complications were compared between the two groups. Results At 1 week, 1 month and 3 months after surgery, the goniosynechialysis group had lower intraocular pressure, better BCVA, deeper central anterior chamber depth, and higher wiVD and diVD than the trabeculectomy group (P<0.05). One month postoperatively, the NEI-VFQ-25 score of the goniosynechialysis group was significantly higher than that of the trabeculectomy group (P<0.05), while no significant difference was observed between the two groups at 3 months after surgery (P>0.05). The overall incidence of complications in the goniosynechialysis group was 6.50%, which was lower than 13.00% in the trabeculectomy group (P<0.05). Conclusion Compared with phacoemulsification combined with trabeculectomy, phacoemulsification combined with goniosynechialysis can effectively control intraocular pressure, increase anterior chamber depth, improve optic disc blood circulation, restore visual acuity, enhance quality of life and reduce the incidence of complications in patients with APACG complicated with cataract.

中青年脑卒中患者早期康复治疗疗效观察

Observation on the Efficacy of Early Rehabilitation Therapy in Young and Middle-aged Stroke Patients

:-
 
目的:探讨早期康复治疗对中青年脑卒中患者肢体运动功能恢复等影响。方法:从我院选取中青年脑卒中患者90例作为实验对象,分为实验组和观察组各45例,两组同时接受相同常规治疗并给予早期康复介入,并对其进行患侧上肢和下肢功能评定量表( Fugl-Meyer, FMMS),以及患者日常生活活动能力(Modified Barthel Index,MBI)评定。实验组给予进一步强化康复运动治疗,以加速提高患者康复速率;2周结束时对实验组和观察组再次进行评估,比较2组患者治疗前后组内和组间治疗疗效。结果:早期康复2周后,实验组FMMS量表上肢评分为(29.82±15.43)分,观察组上肢评分为(21.33±11.98)分,组间存在统计学差异(P=0.005)。实验组FMMS量表下肢评分为(21.18±8.97)分,观察组下肢评分为(15.40±7.40)分,实验组得分高于观察组且两组间存在显著统计学差异(P=0.002);随访1个月后实验组上下肢功能呈持续改善趋势,且两组间差异具有显著统计学意义。实验组MBI量表评分为(35.56±18.93)分,高于对照组(28.56±14.68)分,但未见统计学意义;1个月后两组间差异具有显著统计学意义(P<0.001)。结论:研究表明,早期康复治疗对改善中青年脑卒中患者肢体功能和日常生活活动能力具有显著康复效果。
Objective:Exploring the impact of early rehabilitation therapy on the recovery of limb motor function and other aspects in young and middle-aged stroke patients. Methods: Ninety young and middle-aged stroke patients were selected from our hospital as experimental subjects and divided into two groups, namely the experimental group and the observation group, with 45 cases in each group. Both groups received the same conventional treatment and early rehabilitation intervention simultaneously, and were evaluated using the Fugl-Meyer Motor Scale (FMMS) for the affected upper and lower limbs, as well as the Modified Barthel Index (MBI) for activities of daily living. The experimental group received further intensive rehabilitation exercise therapy to accelerate the rehabilitation rate. At the end of 2 weeks, both groups were reassessed, and the therapeutic effects within and between the two groups before and after treatment were compared. Results: After 2 weeks of early rehabilitation, the FMMS upper limb score in the experimental group was (29.36±15.27) points, while that in the observation group was (25.18±11.99) points, with no statistically significant difference observed between the groups. The FMMS lower limb score in the experimental group was (20.93±8.93) points, higher than that in the observation group (15.40±7.40) points, with a significant statistical difference between the two groups (P=0.002). The MBI score in the experimental group was (33.22±15.96) points, higher than that in the control group (28.56±14.68) points, but no statistical significance was observed. Conclusions: Our study indicates that early rehabilitation therapy has certain effects on upper limb function and activities of daily living in patients, particularly demonstrating significant rehabilitation effects in improving lower limb functional recovery in young and middle-aged stroke patients.

腔镜下双平面假体植入乳房重建术对乳腺癌患者乳房重建疗效及并发症发生率的影响

:-
 
目的 探讨腔镜下双平面假体植入乳房重建术在乳腺癌患者乳房重建中的临床价值。方法 回顾性分析2023年1月至2025年1月于我院行手术治疗的126例乳腺癌患者病例资料,根据术中乳房重建方式分为两组,将采用胸肌前假体植入乳房重建的63例患者纳入对照组,采用腔镜下双平面假体植入乳房重建的63例患者纳入研究组。比较两组围手术期指标、患侧乳房体积、创面瘢痕[温哥华瘢痕量表(VSS)评分]、乳房美观度、生活质量[中文版乳腺癌患者生命质量测定量表(FACT-B)评分]及并发症情况。结果 研究组手术时间长于对照组,术中出血量高于对照组(P<0.05)。两组术后引流量、住院天数比较无显著差异(P>0.05);术后3个月研究组患侧乳房体积大于对照组,VSS评分低于对照组(P<0.05);研究组乳房美观度优良率95.24%高于对照组80.95%(P<0.05);术后3个月,研究组FACT-B总评分高于对照组(P<0.05);两组并发症总发生率比较无显著差异(P>0.05)。结论 乳腺癌患者采用腔镜下双平面假体植入乳房重建术虽在一定程度增加手术时间及术中出血量,但能改善乳房形态,提升美观满意度,改善患者生活质量,且不增加并发症风险。

内界膜翻转覆盖术联合空气填充治疗特发性黄斑裂孔的临床疗效

:-
 
目的:评价在特发性黄斑裂孔(Idiopathic macular hole,IMH)患者的治疗中采用内界膜翻转覆盖术联合空气填充干预的实际价值;方法:选取2022年9月至2025年8月在我院接受手术治疗的42例裂孔直径在400~700μm的IMH患者,以随机数字表法分组,各21例。对照组采取内界膜剥离术联合空气填充进行干预,观察组采取内界膜翻转覆盖术联合空气填充进行干预,比较两组的裂孔闭合情况、最佳矫正视力(Best corrected vision,BCVA)及并发症发生情况;结果:两组患者在裂孔闭合情况率上差异无统计学意义(P>0.05)。但术后3个月观察组的外界膜(External membrane,ELM)及椭圆体带(Ellipsoid zone,EZ)缺损直径均略低于对照组,表明两组在外层视网膜愈合情况上差异有统计学意义(P<0.05)。术后1个月及3个月观察组的BCVA均低于对照组(P<0.05)。两组术后并发症发生率基本一致(P>0.05);结论:对IMH患者采取内界膜翻转覆盖术联合空气填充进行治疗,能够促进黄斑裂孔愈合并改善患者视力,且安全性良好,可广泛应用。

内镜逆行阑尾炎治疗术与腹腔镜阑尾切除术治疗急性化脓性阑尾炎的疗效对比

:-
 
目的 对比内镜逆行阑尾炎治疗术(ERAT)与腹腔镜阑尾切除术(LA)治疗急性化脓性阑尾炎(ASA)的效果。方法 按随机数字表法将2022年7月-2025年12月本院收治的106例SAS患者分为对照组(LA治疗)及观察组(ERAT治疗),各53例。比较两组围手术期指标、术后恢复指标、炎症因子水平[C反应蛋白(CRP)、白介素-6(IL-6)、降钙素原(PCT)]、疼痛介质水平[P物质(SP)、前列腺素E2(PGE2)、5-羟色胺(5-HT)]、免疫功能、胃肠激素[胃泌素(GAS)、血管活性肠肽(VIP)、胃动素(MTL)]、并发症、复发率。结果 观察组较对照组术中出血量更少,手术、住院时间与肛门排气、首次下床活动、体温复常及术后进食时间更短,并发症发生率更低;术后48h的CRP、IL-6、PCT、SP、PGE2、5-HT及VIP水平更低,CD3+、CD4+、CD4+/CD8+与GAS、MTL水平更高,有统计学差异(P<0.05);术后3个月内,两组均无1例复发。结论 与LA治疗ASA相比,ERAT具有创伤小、恢复快、炎症反应轻、并发症少等优势,且对免疫功能、胃肠功能影响小等优势,值得临床借鉴。

改良宫腹腔镜术治疗输卵管积水性不孕症的疗效观察研究

:-
 
目的 探究改良宫腹腔镜术治疗输卵管积水性不孕症(HAI)的效果。方法 回顾性分析2023年6月~2025年3月本院收治的80例HAI患者资料,依据手术方法不同分为对照组(40例,传统宫腹腔镜术)、观察组(40例,改良宫腹腔镜术)。两组术后均随访12个月。对比两组自然妊娠率、输卵管通畅率、积水复发率、手术指标及住院时间及术后并发症发生率;对比两组术前、术后1d、术后3d的C反应蛋白(CRP)、降钙素原(PCT)、D-二聚体(D-D)水平。结果 观察组自然妊娠率、输卵管通畅率较对照组高,积水复发率较低(P<0.05)。两组手术时间、术中出血量对比无差异(P>0.05);观察组住院时间较对照组短,并发症较少(P<0.05)。术后1d、术后3d,两组CRP、PCT、D-D均高于术前,术后3d均低于术后1d,观察组均较对照组低(P<0.05)。结论 改良宫腹腔镜术可以提高HAI患者的自然妊娠率、输卵管通畅率,降低积水复发率,且能减轻患者的术后炎症及高凝状态,降低并发症发生率,缩短住院时间。

槐花散合桃花汤联合FP化疗方案治疗寒热错杂型晚期食管癌患者的多维度疗效评价

Multidimensional efficacy evaluation of Huaihua San and Taohua Decoction combined with FP chemotherapy regimen in the treatment of patients with advanced esophageal cancer of intermingled cold-heat syndrome

:-
 
目的 分析槐花散合桃花汤联合FP(顺铂、5-氟尿嘧啶)化疗方案治疗寒热错杂型晚期食管癌患者的效果。方法 选取我院2023年1月~2024年8月寒热错杂型晚期食管癌患者98例,依照随机数字表法分为两组,各49例。对照组接受FP化疗方案治疗,观察组接受槐花散合桃花汤联合FP化疗方案治疗。比较两组多维度疗效[西医疗效(疾病控制率)、中医疗效]、治疗前后中医证候积分(TCMSS)、肿瘤标志物[鳞状细胞癌抗原(SCC-Ag)、癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)]、生活质量[食管癌生命质量测定量表(QLICP-ES)]、毒副反应、1年生存率。结果 观察组中医疗效(89.80%)较对照组(65.31%)高(P<0.05),而两组疾病控制率比较无明显差异(P>0.05);观察组TCMSS低于对照组(P<0.05);治疗后,观察组CEA、CYFRA21-1、SCC-Ag水平低于对照组(P<0.05);治疗后,观察组QLICP-ES评分低于对照组(P<0.05);观察组恶心呕吐、消化系出血、脱发发生率较对照组低(P<0.05);两组1年生存率对比无明显差异(P>0.05)。结论 槐花散合桃花汤联合FP化疗方案治疗寒热错杂型晚期食管癌,能提高中医疗效,降低患者肿瘤标志物水平,减轻毒副反应,改善中医症状,并有助于减轻化疗对生活质量的负面影响。
Objective To analyze the efficacy of Huaihua San and Taohua Decoction combined with FP (cisplatin, 5-fluorouracil) chemotherapy regimen in the treatment of patients with advanced esophageal cancer of intermingled cold-heat syndrome type. Methods A total of 98 patients with advanced esophageal cancer complicated with intermingled cold-heat syndrome admitted to our hospital from January 2023 to August 2024 were enrolled and divided into two groups by the random number table method, with 49 cases in each group. The control group was treated with FP chemotherapy regimen, and the observation group was treated with Huaihua San and Taohua Decoction combined with FP chemotherapy. Multi-dimensional efficacy indicators [western medicine efficacy (disease control rate) and traditional Chinese medicine (TCM) efficacy], as well as the TCM syndrome score (TCMSS), tumor markers [squamous cell carcinoma antigen (SCC-Ag), carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1)], quality of life [quality of life instrument for cancer patients-esophageal cancer scale (QLICP-ES)] before and after treatment, adverse reactions and 1-year survival rate were compared between the two groups. Results The TCM efficacy rate of the observation group was 89.80%, which was significantly higher than 65.31% of the control group (P<0.05), no significant difference was found in disease control rate between the two groups (P>0.05). The TCMSS of the observation group was lower than that of the control group (P<0.05). After treatment, the levels of CEA, CYFRA21-1 and SCC-Ag in the observation group were lower than those in the control group (P<0.05). The QLICP-ES score of the observation group was superior to the control group after treatment (P<0.05). The incidences of nausea and vomiting, digestive tract hemorrhage and alopecia in the observation group were markedly lower (P<0.05). There was no statistical difference in 1-year survival rate between the two groups (P>0.05). Conclusion The regimen of Huaihua San and Taohua Decoction combined with FP chemotherapy for advanced esophageal cancer of intermingled cold-heat syndrome can improve TCM therapeutic efficacy, reduce the levels of tumor markers, alleviate toxic and side effects, ameliorate TCM symptoms, and lessen the negative impact of chemotherapy on patients quality of life.

活动与固定平台单髁置换早期疗效对比分析

Comparative Analysis of Early Clinical Efficacy Between Mobile-Bearing and Fixed-Bearing Unicompartmental Knee Arthroplasty

:-
 
摘要 目的 分析固定(FB)和活动平台(MB)单髁置换术(UKA)在膝关节内侧间室骨关节炎早期阶段的临床效果与影像学差异,以指导临床假体选择。 方法 本研究回顾性纳入41例确诊为单侧膝关节内侧间室骨关节炎的患者,按照假体类型分为两组:FB组(20例,使用春立XG假体)和MB组(21例,使用春立XK假体)。分别在术前、术后及随访终点统计膝关节屈伸活动范围(ROM)、VAS 疼痛评分、美国特种外科医院膝关节评分(HSS );测量并比较股胫角(FTA)、胫骨假体内外翻角(TCVA)、胫骨假体后倾角(TCPSA);记录围手术期指标及并发症情况。 结果 两组患者术后ROM、VAS、HSS 评分均较术前显著改善(P均<0.0001);末次随访时固定平台组 VAS 评分显著低于活动平台组(P<0.05),而两组间的ROM、HSS 评分无统计学差异(均 P>0.05)。两组术后 FTA、TCVA、TCPSA 均恢复至理想范围,组间均无统计学差异(均 P>0.05)。固定平台组手术时间更短(P<0.05),两组均无严重并发症,假体生存率均为 100%。 结论 活动平台与固定平台单髁置换术均可显著改善膝关节内侧间室骨关节炎患者疼痛、活动度及功能,下肢力线恢复效果相当;固定平台假体在疼痛控制与手术便捷性方面更具优势,临床可根据患者情况与术者经验个体化选择。 关键词 单髁置换术;活动平台假体;固定平台假体;骨关节炎;并发症
Abstract Objective To investigate the early clinical outcomes and radiological differences between fixed-bearing (FB) and mobile-bearing (MB) unicompartmental knee arthroplasty (UKA) in the treatment of medial compartment knee osteoarthritis (OA), and to provide evidence for clinical prosthesis selection. Methods Clinical data of 41 patients with unilateral medial compartment knee OA were retrospectively analyzed. The FB group comprised 20 patients (using Chunli XG prosthesis), and the MB group comprised 21 patients (using Chunli XK prosthesis). Knee range of motion (ROM), Visual Analogue Scale (VAS) pain score, and Hospital for Special Surgery (HSS) knee score were compared between the two groups preoperatively, postoperatively, and at the final follow-up. Femorotibial angle (FTA), tibial component valgus angle (TCVA), and tibial component posterior slope angle (TCPSA) were measured and compared. Perioperative indicators and complications were recorded. Results Postoperative ROM, VAS, and HSS scores significantly improved compared with preoperative values in both groups (all P < 0.0001). At the final follow-up, the VAS score in the FB group was significantly lower than that in the MB group (P < 0.05), while no significant differences were observed in ROM or HSS scores between the two groups (all P > 0.05). Postoperative FTA, TCVA, and TCPSA values returned to the ideal range in both groups, with no significant intergroup differences (all P > 0.05). The FB group had a significantly shorter operative time (P < 0.05). No severe complications occurred in either group, and the prosthesis survival rate was 100% in both groups. Conclusion Both FB-UKA and MB-UKA significantly improve pain, range of motion, and function in patients with medial compartment knee OA, with comparable efficacy in restoring lower limb alignment. The FB prosthesis offers advantages in pain control and surgical convenience. Clinical selection may be individualized based on patient characteristics and surgeon experience. Keywords Unicompartmental knee arthroplasty; Mobile-bearing prosthesis; Fixed-bearing prosthesis; Osteoarthritis; Complications
出版者信息








《广州医药》公众号